2010

Aktas O, Kieseier BC, Hartung HP. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends in Neurosciences 2010; 33: 140-152.

Aktas O, Küry P, Kieseier BC, Hartung HP. Fingolimod is a potential novel therapy for multiple sclerosis. Nature Reviews Neurology 2010; 6: 373-382.

Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, Methner A. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system x(c)- as a neuroprotective drug target. CNS & Neurological Disorders Drug Targets 2010; 9: 373-382.

Arendt G, Nolting T. Immune reconstitution inflammatory syndrome in HIV-positive patients: a relatively new and not fully understood phenomenon. HIV Therapy 2010; 4: 577-587.

Arendt G, Nolting T. Psychiatrische Störungen bei HIV-positiven Patienten. Arzneimitteltherapie 28: 269-276.

Awad A, Hemmer B, Hartung HP, Kieseier BC, Bennett JL, Stuve O. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. Journal of Neuroimmunology 2010; 219: 1-7.

Bakheit AM, Zakine B, Maisonobe P, Aymard C, Fhedoroff K, Hefter H, Jacinto J, Jost WH, Molteni F, Stam H, Turner-Stokes L, Wissel J. The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey. International Journal of Rehabilitation Research 2010; 33: 199-204.

Barnes M, Schnitzler A, Medeiros L, Aguilar M, Lehnert-Batar A, Minnasch P. Efficacy and safety of NT 201 for upper limb spasticity of various etiologies - a randomized parallel-group study. Acta Neurologica Scandinavica 2010; 122: 295-302.

Becker JS, Zoriy M, Matusch A, Wu B, Salber D, Palm C, Becker JS. Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). Mass Spectrometry Reviews 2010; 29: 156-175.

Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, Wolinsky JS, Ziemssen T. Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Annals of Neurology 2010; 68: 409-411.

Braun S, Werdehausen R, Gaza N, Hermanns H, Kremer D, Küry P, Hollmann MW, Stevens MF. Benzethonium increases the cytotoxicity of s(+)-ketamine in lymphoma, neuronal, and glia cells. Anesthesia and Analgesia 2010; 111: 1389-1393.

Bril V, Banach M, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, et al.; on behalf of the ICE Study Group. Electrophysiologic correlations with clinical outcomes in CIDP. Muscle & Nerve 2010; 42: 492-497.

Brinkmeyer J, Mobascher A, Warbrick T, Musso F, Wittsack HJ, Saleh A, Schnitzler A, Winterer G. Dynamic EEG-informed fMRI modeling of the pain matrix using 20-ms root mean square segments. Human Brain Mapping 2010; 31: 1702-1712.

Butz M, Timmermann L, Braun M, Groiss SJ, Wojtecki L, Ostrowski S, Krause H, Pollok B, Gross J, Südmeyer M, Kircheis G, Häussinger D, Schnitzler A. Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurologica Scandinavica2010; 122: 27-35.

Chun J, Hartung HP. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clinical Neuropharmacology 2010; 33: 91-101.

Classen J, Schnitzler A. What does the pedunculopontine nucleus do? Neurology 2010; 75: 944-945.

Clifford DB, DeLuca A, Simpson DM, Arendt G, Giovannoni G, Nath A. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurology 2010; 9: 438-446.

Cohen CA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; for the TRANSFORMS Study Group. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. New England Journal of Medicine 2010; 362: 402-415.

Comi G, O'Connor P, Montalban X, Antel J, Radue EW, Karlsson G, Pohlmann H, Aradhye S, Kappos L, FTY720D2201 Study Group [Goebels N]. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. Multiple Sclerosis 2010; 16: 197-207.

Daniels C, Krack P, Volkmann J, Pinsker MO, Krause M, Tronnier V, Kloss M, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G, Witt K. Risk factors for executive dysfunction after subthalamic nucelus stimulation in Parkinson's disease. Movement Disorders 2010; 25: 1583-1589.

Dengler R, Diener HC, Schwartz A, Grond M, Schumacher H, Machnig T, Eschenfelder CC, Leonard J, Jander S, et al.; on behalf of the EARLY Investigators. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurology 2010; 9: 159-166.

Diserens K, Ruegg D, Kleiser R, Hyde S, Perret N, Vuadens P, Fornari E, Vingerhoets F, Seitz RJ. Effect of repetitive arm cycling following botulinum toxin injection for poststroke spasticity: evidence from fMRI. Neurorehabilitation & Neural Repair 2010; 24: 753-762.

Donofrio PD, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Hughes R, Latov N, Merkies I, van Doorn P; IGIV-C CIDP Efficacy (ICE) Study Group. Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy. Archives of Neurology 2010; 67: 1082-1088.

Ebert D, Georgas E, Rosenthal D, Wibowo C, Massing T, Barth T, Hefter H. Phase relations between rhythmical movements and breathing in Wilson's disease. Advances in Experimental Medicine and Biology 2010; 669: 231-234.

Florin E, Gross J, Reck C, Maarouf M, Schnitzler A, Sturm V, Fink GR, Timmermann L. Causality between local field potentials of the subthalamic nucleus and electromyograms of forearm muscles in Parkinson's disease. European Journal of Neuroscience 2010; 31: 491-498.

Franzkowiak S, Pollok B, Biermann-Ruben K, Südmeyer M, Paszek J, Jonas M, Thomalla G, Bäumer T, Orth M, Münchau A, Schnitzler A. Altered pattern of motor cortical activation-inhibition during voluntary movements in Tourette syndrome. Movement Disorders 2010; 25: 1960-1966.

Genêt F, Schnitzler A, Mathieu S, Autret K, Théfenne L, Dizien O, Maldjian A. Orthotic devices and gait in polio patients. Annals of Physical and Rehabiliation Medicine 2010; 53: 51-59.

Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group [Kieseier BC]. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. New England Journal of Medicine 2010; 362: 416-426.

Göttle P, Kremer D, Jander S, Ödemis V, Engele J, Hartung HP, Küry P. Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Annals of Neurology 2010; 68: 915-924.

Hahn K, Husstedt IW, Arendt G. Deutsche Neuro-AIDS-Arbeitsgemeinschaft (DNAA). HIV-assoziierte Neuropathien. Nervenarzt 2010; 81: 409-417.

Hartung HP, Kieseier BC, Aktas O. Cladribin: Entwicklung einer oralen Formulierung zur Behandlung der Multiplen Sklerose. Nervenarzt 2010; 81: 194-202.

Hartung HP, Aktas O, Kieseier BC, Comi G. Development of oral cladribine for the treatment of multiple sclerosis. Journal of Neurology 2010; 257: 163-170.

Hartung HP, Kieseier BC. Atacicept: targeting B cells in multiple sclerosis. Therapeutic Advances in Neurological Disorders 2010; 3: 205-216.

Hartung HP, Aktas O. Oral therapies for multiple sclerosis: are we there yet? Lancet Neurology 2010; 9: 454-457.

Herrmann AM, Göbel K, Simon OJ, Melzer N, Schuhmann MK, Stenner MP, Weishaupt A, Kleinschnitz C, Bittner S, Meuth P, Stuve O, Budde T, Kieseier BC, Wiendl H, Meuth SG. Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death. American Journal of Pathology 2010; 177: 3051-3060.

Hölscher S, Leinweber B, Hefter H, Reuner U, Günther P, Weiss KH, Oertel WH, Möller JC. Evaluation of the symptomatic treatment of residual neurological symptoms in Wilson disease. European Neurology 2010; 64: 83-87.

Hofstetter HH, Forsthuber TG. Kinetics of IL-17- and interferon-gamma-producing PLPp-specific CD4 T cells in EAE induced by coinjection of PLPp/IFA with pertussis toxin in SJL mice. Neuroscience Letters 2010; 476: 150-155.

Hu W, Nessler S, Hemmer B, Eagar TN, Kane LP, Leliveld SR, Müller-Schiffmann A, Gocke AR, Lovett-Racke A, Ben LH, Hussain RZ, Breil A, Elliott JL, Puttaparthi K, Cravens PD, Singh MP, Petsch B, Stitz L, Racke MK, Korth C, Stüve O. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling. Brain 2010; 133: 375-388.

Huehnchen P, Prozorovski T, Klaissle P, Lesemann A, Ingwersen J, Wolf SA, Kupsch A, Aktas O, Steiner B. Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation. Glia 2010; 59: 132-142.

Husseini L, Leussink VI, Kieseier BC, Hartung HP. 4-Aminopyridin (Fampridin) - ein neuer Ansatz zur symptomatischen Therapie der Multiplen Sklerose. Nervenarzt 2010; 81: 203-211.

Jonas M, Thomalla G, Biermann-Ruben K, Siebner HR, Müller-Vahl K, Bäumer T, Gerloff C, Schnitzler A, Orth M, Münchau A. Imitation in patients with Gilles de la Tourette syndrome - a behavioral study. Movement Disorders 2010; 25: 991-999.

Kägi G, Missimer JH, Abela E, Seitz RJ, Weder BJ. Neural networks engaged in tactile object manipulation: patterns of expression among healthy individuals. Behavioral and Brain Functions 2010; 6: 71.

Kalluri SR, Illes Z, Srivastava R, Cree B, Menge T, Bennett JL, Berthele A, Hemmer B. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Archives of Neurology 2010; 67: 1201-1208.

Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group [Kieseier BC]. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. New England Journal of Medicine 2010; 362: 387-401.

Kieseier BC, Hartung HP. Bioavailability of interferon-beta in patients with multiple sclerosis - fishing for the surrogate. European Journal of Neurology 2010; 17: 344-345.

Kieseier BC, Wiendl H. Postpartum disease activity and breastfeeding in multiple sclerosis revisited. Neurology 2010; 75: 392-393.

Kieseier BC, Hohlfeld R. Regulatory T cells in myositis - good samaritans at the site of inflammation? Journal of Neuroimmunology 2010; 226: 1-2.

Kieseier BC, Lehmann HC, Meyer zu Hörste G. Klinische Studien und Therapieoptionen bei Immunneuropathien. Nervenheilkunde 2010; 29: 723-728.

Kieseier BC, Jeffery DR. Chemotherapeutics in the treatment of multiple sclerosis. Therapeutic Advances in Neurological Disorders 2010; 3: 277-291.

Kieseier BC. Entzündliche Neuropathien. In: Stangel (ed.) Immunglobuline in der Neurologie. Uni-med Verlag, Bremen, 2010, pp 35-48.

Kleiser R, Rademacher GU, Niedeggen A, Müller HW, Seitz RJ. Assessment of gadolinium leakage into traumatic spinal cord lesion using magnet resonance imaging. Spine 2010; 35: E1604-1609.

Krause V, Pollok B, Schnitzler A. Perception in action: the impact of sensory information on sensorimotor synchronization in musicians and non-musicians. Acta Psychologica (Amst.) 2010; 133: 28-37.

Krause V, Schnitzler A, Pollok B. Functional network interactions during sensorimotor synchronization in musicians and non-musicians. Neuroimage 2010; 52: 245-251.

Kremer D, Aktas O, Hartung HP, Küry P. Immunobiology of the oligodendrocyte. In: Armati P (ed.) The Biology of Oligodendrocytes Cambridge University Press, 2010; 115-136.

Latov N, Deng C, Dalakas MC, Bril V, Donofrio P, Hanna K, Hartung HP, Hughes RA, Merkies IS, van Doorn PA; for the IGIV-C CIDP Efficacy (ICE) Study Group. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Archives of Neurology 2010; 67: 802-807.

Lehmann HC, Jangouk P, Kierysch EK, Meyer zu Hörste G, Hartung HP, Kieseier BC. Autoantibody-mediated dysfunction of sympathetic neurons in Guillain-Barré syndrome. Archives of Neurology 2010; 67: 203-210.

Lehmann HC, Zhang J, Mori S, Sheikh KA. Diffusion tensor imaging to assess axonal regeneration in peripheral nerves. Experimental Neurology 2010; 223: 238-244.

Lehmann HC, Hoffmann F, Meyer zu Hörste G, Hartung HP, Kieseier BC. Central nervous system involvement in patients with monoclonal gammopathy and polyneuropathy. European Journal of Neurology 2010; 17: 1075-1081.

Lehmann HC, Hartung HP, Kieseier BC, Hughes RA. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infectious Diseases 2010; 10: 643-651.

Lehmann HC, Hartung HP. Varicella-zoster virus: another trigger of Guillain-Barré syndrome? Clinical Infectious Diseases 2010; 51: 531-533.

Lehmann HC, Höke A. Schwann cells as a therapeutic target for peripheral neuropathies. CNS & Neurological Disorders Drug Targets 2010; 9: 801-806.

Leussink VI, Meyer zu Hörste G, Hartung HP, Stüve O, Kieseier BC. Natalizumab bei fulminanter Multipler Sklerose - nicht immer erfolgreich. Nervenheilkunde 2010; 9: 3-7.

Leussink VI, Stüve O, Meyer zu Hörste GKieseier BC. Immunmodulation in multiple sclerosis. Hot Topics in Neurology & Psychiatry 2010; 3: 17-22.

Lopez PH, Zhang G, Zhang J, Lehmann HC, Griffin JW, Schnaar RL, Sheikh KA. Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair. Journal of Neuroscience 2010; 30: 9533-9541.

Matusch A, Depboylu C, Palm C, Wu B, Höglinger GU, Schäfer MK, Becker JS Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson's disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). Journal of the American Society for Mass Spectrometry 2010; 21: 161-171.

Merkies IS, Hughes RA, Donofrio P, Bril V, Dalakas MC, Hanna K, Hartung HP, Latov N, van Doorn PA, Deng C; on behalf of the ICE Study Group. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. Journal of the Peripheral Nervous System 2010; 15: 208-215.

Meuth SG, Bittner S, Ulzheimer JC, Kleinschnitz C, Kiesier BC, Wiendl H. Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of neuroprotective and alternative treatment strategies. BioDrugs 2010; 24: 317-330.

Meyer zu Hörste G, Heidenreich H, Mausberg AK, Lehmann HC, ten Asbroek AL, Saavedra JT, Baas F, Hartung HP, Wiendl H, Kieseier BC. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation. Neurobiology of Disease 2010; 37: 483-490.

Meyer zu Hörste G, Zozulya AL, El-Haddad H, Lehmann HC Hartung HP, Wiendl H, Kieseier BC. Active immunization induces toxicity of diphtheria toxin in diphtheria resistant mice - implications for neuroinflammatory models. Journal of Immunological Methods 2010; 354: 80-84.

Meyer zu Hörste G, Heidenreich H, Lehmann HC, Ferrone S, Hartung HP, Wiendl H, Kieseier BC. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies. Glia 2010; 58: 80-92.

Meyer zu Hörste G, Mausberg AK, Korth C, Stüve O, Kieseier BC. Quinpramine-A promising compound for treating immune-mediated demyelination of the nervous system. Drug News & Perspectives 2010; 23: 287-294.

Missimer JH, Seitz RJ, Kleiser R. Data-driven analyses of an fMRI study of a subject experiencing phosphenes. Journal of Magnetic Resonance Imaging 2010; 31: 821-828.

Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK. Animal models of multiple sclerosis - potentials and limitations. Progress in Neurobiology 2010; 92: 386-404.

Mobascher A, Brinkmeyer J, Thiele H, Toliat MR, Steffens M, Warbrick T, Musso F, Wittsack HJ, Saleh A, Schnitzler A, Winterer G. The val158met polymorphism of human catechol-O-methyltransferase (COMT) affects anterior cingulate cortex activation in response to painful laser stimulation. Molecular Pain 2010; 6: 32.

Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Schnitzler A, Timmermann L, Wojtecki L, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Movement Disorders 2010; 25: 578-586.

Ödemis V, Boosmann K, Heinen A, Küry P, Engele J. CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. Journal of Cell Science 2010; 123: 1081-1088.

Paszek J, Pollok B, Biermann-Ruben K, Müller-Vahl K, Roessner V, Thomalla G, Robertson MM, Orth M, Schnitzler A, Münchau A. Is it a tic? - Twenty seconds to make a diagnosis. Movement Disorders 2010; 25: 1106-1108.

Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, Fainardi E, Franciotta D, Freedman M, Giedraitis V, Gilhus NE, Giovannoni G, Glabinski A, Grieb P, Hartung HP, Hemmer B, et al. Neurofilament ELISA validation. Journal of Immunological Methods 2010; 352: 23-31.

Polman CH, Bertolotto A, Deisenhammer F, Giovannoni G, Hartung HP, Hemmer B, Killestein J, McFarland HF, Oger J, Pachner AR, Petkau J, Reder AT, Reingold SC, Schellekens H, Soelberg-Sorensen P. Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis. Lancet Neurology 2010; 9: 740-750.

Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Hartung HP, et al.; on behalf of the SENTINEL Investigators. Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. Journal of the Neurological Sciences 2010; 292: 28-35.

Reck C, Himmel M, Florin E, Maarouf M, Sturm V, Wojtecki L, Schnitzler A, Fink GR,

Timmermann L. Coherence analysis of local field potentials in the subthalamic nucleus: differences in parkinsonian rest and postural tremor. European Journal of Neuroscience 2010; 32: 1202-1214.

Rivera F, Steffenhagen C, Kremer D, Kandasamy M, Sandner B, Couillard-Despres S, Weidner N, Küry P, Aigner L. Deciphering the oligodendrogenic program of neural progenitors: cell intrinsic and extrinsic regulators. Stem Cells and Development 2010; 19: 595-606.

Scheller C, Arendt G, Nolting T, Antke C, Sopper S, Maschke M, Obermann M, Angerer A, Husstedt IW, Meisner F, Neuen-Jacob E, Müller HW, Carey P, Ter Meulen V, Riederer R, Koutsilieri E. Increased dopaminergic neurotransmission in therapy-naive asymptoma tic HIV patients is not associated with adaptive changes at the dopaminergic synpases. Journal of Neural Transmission 2010; 117: 699-705.

Schneider F, Reske M, Finkelmeyer A, Wojtecki L, Timmermann L, Brosig T, Backes V, Amir-Manavi A, Sturm V, Habel U, Schnitzler A. Predicting acute affective symptoms after deep brain stimulation surgery in Parkinson's disease. Stereotactic and Functional Neurosurgery 2010; 88: 367-373.

Schnitzler A, Leffers KW, Häck HJ. High compliance with rotigotine transdermal patch in the treatment of idiopathic Parkinson's disease. Parkinsomism & Related Disorders 2010; 16: 513-516.

Schnitzler A, Fuchs G, Baas H, Dillmann U, Hilker R, Oechsner M. Brauchen wir eine frühzeitige tiefe Hirnstimulation beim Morbus Parkinson? Fortschritte der Neurologie - Psychiatrie 2010; 78 S: 37-40.

Schwab N, Zozulya AL, Kieseier BC, Toyka KV, Wiendl H. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. Journal of Immunology 2010; 184: 5368-5374.

Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schröter F, Prozorovski T, Lange N, Steffen J, Rieger M, Kuckelkorn U, Aktas O, Kloetzel PM, Krüger E. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 2010; 142: 613-624.

Seitz RJ. Stroke recovery: the pyramid in focus. Neurology 2010; 74: 276-277.

Seitz RJ. How imaging will guide rehabilitation. Current Opinion in Neurology 2010; 23: 79-86.

Seitz RJ, Donnan GA. Role of neuroimaging in promoting long-term recovery from ischemic stroke. Journal of Magnetic Resonance Imaging 2010; 32: 756-772.

Sellner J, Cepok S, Kalluri SR, Nestler A, Kleiter I, Kümpfel T, Linker R, Melms A, Menge T, Tumani H, Paul F, Hemmer B, Berthele A. Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses. Neurochemistry International 2010; 57: 662-667.

Smolianov V, Dehmel T, Vollmar P, Kieseier BC, Hemmer B, Hartung HP, Hofstetter H. Alteration of T cell cytokine production in PLPp 139-151-induced EAE in SJL mice by an immunostimulatory CpG oligonucleotide. Journal of Neuroinflammation 2010, in press.

Sominanda A, Lundkvist M, Fogdell-Hahn A, Hemmer B, Hartung HP, Hillert J, Menge T, Kieseier BC. Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta. Archives of Neurology 2010; 67: 1095-1101.

Sørensen PS, Bertolotto A, Edan G, Giovannoni G, Gold R, Havrdova E, Kappos L, Kieseier BC, Montalban X, Olsson T. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Multiple Sclerosis 2012; 18: 143-152.

Stangel M, Kieseier BC. Pharmacotherapy options for multiple sclerosis: focus on natalizumab. Clinical Medicine Insights: Therapeutics 2010; 2: 1-6.

Stüve O, Kieseier BC, Hemmer B, Hartung HP, Awad A, Frohman EM, Greenberg BM, Racke MK, Zamvil SS, Phillips JT, Gold R, Chan A, Zettl U, Milo R, Marder E, Khan O, Eagar TN. Translational research in neurology and neuroscience 2010: multiple sclerosis. Archives of Neurology 2010; 67: 1307-1315.

Tamagno G, Celik Y, Simó R, Dihné M, Kimura K, Gelosa G, Lee BI, Hommet C, Murialdo G. Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes. BMC Neurology2010; 10: 27.

Timmermann L, Pauls KA, Wieland K, Jech R, Kurlemann G, Sharma N, Schnitzler A, et al. Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain 2010; 133: 701-712.

Toutzaris D, Lewerenz J, Albrecht P, Jensen LT, Letz J, Geerts A, Golz S, Methner A. A novel giant peroxisomal superoxid dismutase motif-containing protein Free Radical Biology & Medicine 2010; 48: 811-820.

Tsoumakidou G, Buy X, Zickler P, Zupan M, Douchet MP, Gangi A. Life-threatening complication during percutaneous ablation of adrenal gland metastasis: Takotsubo syndrome. Cardiovascular and Interventional Radiology 2010; 33: 646-649.

Ulzheimer JC, Meuth SG, Bittner S, Kleinschnitz C, Kieseier BC, Wiendl H. Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies. BioDrugs 2010; 24: 249-274.

van den Elskamp IJ, Knol DL, Vrenken H, Karas G, Meijerman A, Filippi M, Kappos L, Fazekas F, Wagner K, Pohl C, Sandbrink R, Polman CH, Uitdehaag BM, Barkhof F. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis. Multiple Sclerosis 2010; 16: 660-669.

van den Elskamp IJ, Boden B, Dattola V, Knol DL, Filippi M, Kappos L, Fazekas F, Wagner K, Pohl C, Sandbrink R, Polman CH, Uitdehaag BM. Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology 2010; 52: 875-881.

von Büdingen HC, Gulati M, Kuenzle S, Fischer K, Rupprecht TA, Goebels N. Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce 'oligoclonal bands'. Journal of Neuroimmunology2010; 218: 134-139.

Warnke C, Menge T, Hartung HP, Racke MK, Cravens PD, Bennett JL, Frohman EM, Greenberg BM, Zamvil SS, Gold R, Hemmer B, Kieseier BC, Stüve O. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? Archives of Neurology 2010; 67: 923-930.

Warnke C, Wiendl H, Hartung HP, Stüve O, Kieseier BC. Identification of targets and new developments in the treatment of multiple sclerosis-focus on cladribine. Drug Design, Development & Therapy 2010; 4: 117-126.

Warnke C, Leussink VI, Kieseier BC, Hartung HP. Interferon b bei Multipler Sklerose. Nervenarzt 2010; 81: 1476-1482.

Warnke C, Meyer zu Hörste G, Kieseier BC. Jenseits der Interferone - Aktuelles und Zukünftiges zur MS Therapie. Nervenheilkunde 2010; 9: 3-7.

Wiendl H, Kieseier BC. Multiple Sklerose. Kohlhammer, Stuttgart, 2010.

Wolf C, Menge T, Stenner MP, Meyer zu Hörste G, Saleh A, Hartung HP, Wiendl H, Kieseier BC. Natalizumab in a patient with chronic inflammatory demyelinating polyneuropathy. Archives of Neurology 2010; 67: 881-883.

Zickler P, Küry P, Gliem M, Hartung HP, Jander S. Differential patterns of local gene regulation in crush lesions of the rat optic and sciatic nerve: relevance to posttraumatic regeneration. Cellular Physiology & Biochemistry 2010; 26: 483-494.

MediathekInformation und Wissen
LageplanSo finden Sie uns